Menu
Gastrointestinal Agents Tablet

Sulfasalazine

500mg

Active Ingredient
Sulfasalazine
Estimated Price
Not specified

Prodrug split by colonic bacteria (5-ASA + sulfapyridine).

Author Profile Picture
Medically Reviewed By
Dr. Amro Algoshae
prominent physician, expert, and consultant in the fields of pharmaceutical marketing, healthcare marketing, and medical facilities management in Yemen.
Medical Disclaimer The information provided in this comprehensive guide is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with your physician before taking any new medication.

Introduction to Sulfasalazine

Sulfasalazine (often marketed as Azulfidine) is a foundational disease-modifying antirheumatic drug (DMARD) and a sulfonamide derivative that has been a cornerstone in the treatment of chronic inflammatory conditions for decades. Originally synthesized in the 1930s to treat rheumatoid arthritis, it was later discovered to be highly effective in managing inflammatory bowel disease (IBD).

As a "prodrug," Sulfasalazine is unique in its delivery system. It is composed of 5-aminosalicylic acid (5-ASA) linked to sulfapyridine by an azo bond. This structure is critical to its function, as it allows the drug to pass through the upper gastrointestinal tract largely intact, reaching the colon where it is metabolized.

Mechanism of Action: How Sulfasalazine Works

The therapeutic efficacy of Sulfasalazine is attributed to its cleavage in the colon by bacterial azoreductases. This process releases two distinct components: 5-aminosalicylic acid (mesalamine) and sulfapyridine.

1. The Role of 5-Aminosalicylic Acid (5-ASA)

The 5-ASA component acts locally within the gastrointestinal tract. It is believed to exert anti-inflammatory effects by:
* Inhibiting the production of prostaglandins and leukotrienes.
* Scavenging free radicals.
* Inhibiting the activation of nuclear factor-kappa B (NF-κB), a key regulator of inflammatory cytokines.

2. The Role of Sulfapyridine

The sulfapyridine moiety is absorbed systemically and is responsible for the drug’s immunomodulatory effects in systemic conditions like rheumatoid arthritis. Its exact mechanism in RA is not fully elucidated, but it is thought to:
* Inhibit T-cell proliferation.
* Modulate the production of cytokines (IL-1, IL-6, and TNF-alpha).
* Inhibit B-cell function and antibody production.

Pharmacokinetics

Understanding the movement of the drug through the body is essential for clinical dosing:

Parameter Description
Absorption 10-30% is absorbed in the small intestine. The remainder reaches the colon.
Metabolism Cleaved by colonic bacteria into 5-ASA and sulfapyridine.
Distribution Sulfapyridine is widely distributed; 5-ASA remains primarily in the gut wall.
Excretion Sulfapyridine is acetylated in the liver and excreted via kidneys.
Half-life Approximately 6 to 10 hours for Sulfasalazine; 5-10 hours for Sulfapyridine.

Clinical Indications and Usage

Sulfasalazine is indicated for several chronic inflammatory disorders where immune modulation or localized gut anti-inflammatory action is required.

Rheumatoid Arthritis (RA)

It is used as a first-line DMARD for early or established RA. It is particularly effective in reducing joint swelling, morning stiffness, and improving functional status.

Inflammatory Bowel Disease (IBD)

  • Ulcerative Colitis: Highly effective for the induction and maintenance of remission in mild-to-moderate disease.
  • Crohn’s Disease: Utilized primarily for colonic involvement, though its efficacy is often considered secondary to other biologics or localized therapies.

Ankylosing Spondylitis and Psoriatic Arthritis

Sulfasalazine is frequently prescribed off-label for the peripheral joint involvement associated with these spondyloarthropathies.

Dosage Guidelines

Dosing must be individualized based on the patient's condition and tolerance.

Rheumatoid Arthritis Dosing

  • Initial: 500 mg daily.
  • Titration: Increase by 500 mg weekly to minimize GI side effects.
  • Maintenance: Typically 2 grams per day, divided into two doses. Maximum dose is usually 3 grams daily.

Ulcerative Colitis Dosing

  • Acute Phase: 3 to 4 grams daily, divided into 3 to 4 doses.
  • Maintenance: 2 grams daily.

Contraindications and Risks

Absolute Contraindications

  • Sulfonamide or Salicylate Allergy: Patients with documented hypersensitivity to these compounds must avoid Sulfasalazine.
  • Porphyria: Can precipitate acute attacks.
  • Intestinal or Urinary Obstruction: Mechanical blockage renders the drug ineffective or dangerous.

Important Warnings

  1. Hematological Monitoring: Sulfasalazine can cause bone marrow suppression, including agranulocytosis and aplastic anemia. Complete Blood Counts (CBC) should be monitored regularly.
  2. Liver Function: Hepatotoxicity, though rare, has been reported.
  3. Sperm Count: Reversible oligospermia and infertility have been observed in men. This effect typically resolves within 2–3 months of discontinuing the drug.
  4. Discoloration: The drug may turn urine or skin an orange-yellow color; this is harmless but should be communicated to the patient.

Drug Interactions

Sulfasalazine can interact with several common medications:

  • Folic Acid: Sulfasalazine inhibits folate absorption. Patients should be supplemented with 1 mg of folic acid daily to prevent deficiency.
  • Digoxin: Sulfasalazine may decrease the absorption of digoxin.
  • Warfarin: May displace warfarin from protein-binding sites, potentially increasing the anticoagulant effect.
  • Antibiotics: May alter the gut flora, potentially reducing the efficacy of the drug by preventing the cleavage of the azo bond.

Pregnancy and Lactation

  • Pregnancy: Sulfasalazine is generally considered safe during pregnancy. It is a category B drug. However, because it inhibits folate absorption, pregnant patients should maintain strict folic acid supplementation.
  • Lactation: Sulfapyridine is excreted into breast milk. It should be used with caution in nursing mothers, particularly if the infant is premature or has hyperbilirubinemia, due to the risk of kernicterus.

Overdose Management

Symptoms of overdose include nausea, vomiting, gastric distress, and abdominal pain.
* Management: There is no specific antidote. Treatment is supportive.
* Action: Induce emesis or perform gastric lavage if ingestion is recent. Monitor renal function to ensure adequate hydration and output, as sulfapyridine can cause crystalluria.

Frequently Asked Questions (FAQ)

1. How long does it take for Sulfasalazine to work?

Sulfasalazine is a DMARD, meaning it is not a painkiller. It typically takes 6 to 12 weeks to see significant clinical improvement in joint inflammation.

2. Why do I need to take Folic Acid with this medication?

Sulfasalazine interferes with the body's ability to absorb folate from food. Supplementing with folic acid prevents side effects like mouth sores and anemia.

3. Does Sulfasalazine cause weight gain?

No, Sulfasalazine is not associated with weight gain. In fact, some patients report weight loss or nausea initially, which may lead to a decrease in appetite.

4. Can I drink alcohol while taking Sulfasalazine?

While there is no strict contraindication, alcohol can exacerbate gastric irritation and increase the burden on the liver. Moderation is advised.

5. Will this medication affect my fertility?

In men, Sulfasalazine can cause a decrease in sperm count and motility. This is usually temporary and reversible upon stopping the medication. There is no evidence of long-term female infertility.

6. What should I do if I miss a dose?

Take the dose as soon as you remember. If it is nearly time for your next dose, skip the missed one. Do not double up on doses.

7. Is it normal for my urine to turn orange?

Yes. Sulfasalazine contains a dye component that can harmlessly turn urine and sweat a bright orange-yellow color.

8. What blood tests are required while on this drug?

Patients should have a CBC, liver function tests (LFTs), and renal function tests (creatinine) monitored periodically—usually every 2–4 weeks initially, then every 3 months.

9. Can children take Sulfasalazine?

Yes, it is often used in children to treat juvenile idiopathic arthritis (JIA) and pediatric IBD, but dosing must be strictly calculated based on body weight.

10. Does Sulfasalazine interact with other biologics?

It is often used in combination with other DMARDs (like methotrexate) or biologics, but such combinations must be managed by a rheumatologist to monitor for additive toxicity, especially regarding the bone marrow.

Disclaimer: This guide is for educational purposes only and does not constitute medical advice. Always consult with a licensed healthcare provider or rheumatologist before starting, stopping, or changing the dosage of any prescription medication.

Share this guide: